Is cell therapy commercially viable?
Cell therapies have huge potential for the treatment of a range of human diseases including cancer, metabolic disorders, tissue degradation and immune deficiencies. Before these therapies can be effectively commercialized for widespread and cost-effective clinical use, however, there is a need to find robust, repeatable and scalable ways to generate large volumes of cells and test to ensure they are a safe and effective therapy.
There are difficulties in commercializing these products so that they are available at an affordable cost to a great number of patients because of the fragile and individualistic nature of cell therapies. There are two inter-related key requirements: the ability to generate huge quantities of cells (millions, even billions) and the ability to produce small numbers of personalized cells at scale – automating current complex and manually intensive processes.
Read the full article, published in Cell & Gene therapy insights